Complete VIVS Stock Valuation Analysis

Comprehensive intrinsic value analysis using 1 different methodologies

VIVS Peer Valuation Analysis

Relative valuation based on comparable company trading multiples

Peer Valuation Analysis

Fair Value Range Analysis

Based on median multiples from 6 peer companies in Healthcare

P/E Ratio
$-0.09
-106.0%
Peer Median: 0.0x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$0.09
-94.3%
Peer Median: 1.8x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for VIVS's business model and current situation.
Multiple Comparison
MultipleVIVS CurrentPeer MedianPeer AveragePremium/DiscountAssessment
P/E Ratio-0.2x0.0x0.0x-1775.3%
Undervalued
EV/EBITDAInfinityx0.0x0.0xInfinity%
Overvalued
P/S Ratio32.0x1.8x1.6x1644.6%
Overvalued
Peer Companies
Click any company to view their valuation
CompanyMarket CapP/E RatioEV/EBITDAP/S Ratio
$0.00B0.0x0.0x0.0x
$0.00B0.0x0.0x1.8x
$0.01B0.0x0.0x0.0x
$0.00B0.0x0.0x32.0x
$0.00B0.0x0.0x1.3x
$0.00B0.0x0.0x64.9x